TL;DR: Aetna, a CVS Health company, modified CPB 0858 covering organ prolapse selected procedures, effective January 5, 2026. Eleven procedures are now explicitly classified as experimental or unproven — including biodegradable cog threads, pectopexy, and vNOTES techniques — while five surgical and imaging approaches retain medical necessity status. Here's what billing teams need to do.
If your practice performs pelvic organ prolapse procedures and bills Aetna, this update sharpens the line between covered and non-covered care. The Aetna organ prolapse coverage policy under CPB 0858 now calls out specific procedures by name on both sides of that line. Codes like 0487T (vaginal tactile imaging), 0552T (low-level laser therapy), and the molecular pathology series 81400–81474 are all explicitly tied to non-covered indications. That's exposure your billing team needs to flag before claims go out.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Organ Prolapse: Selected Procedures |
| Policy Code | CPB 0858 |
| Change Type | Modified |
| Effective Date | January 5, 2026 |
| Impact Level | High |
| Specialties Affected | Urogynecology, colorectal surgery, gynecologic surgery, pelvic floor therapy, radiology |
| Key Action | Audit your charge capture for 0487T, 0552T, +57267, 57284, 57285, and the 81400–81474 molecular pathology range against current medical necessity documentation |
Aetna Organ Prolapse Coverage Criteria and Medical Necessity Requirements 2026
The Aetna organ prolapse coverage policy is built around five procedures that meet medical necessity. None of them are new to clinical practice. What's new is the explicit codified structure — Aetna is now drawing a sharper line, and your documentation needs to match each criterion exactly.
Dynamic MRI is covered for complex organ prolapse, but only as a supplement to physical examination — not as a standalone workup. If your ordering provider is using it as a first-line diagnostic, that claim will likely face a medical necessity denial.
Laparoscopic suture rectopexy is covered for rectal prolapse specifically. Only the laparoscopic approach is explicitly listed as medically necessary under this policy. Document the approach clearly in your operative report and on the claim.
LeFort colpocleisis is covered for severe utero-vaginal prolapse, but Aetna requires two additional patient criteria: the patient must be elderly or chronically ill, and must no longer desire coital function. Both criteria need explicit documentation in the clinical record before you submit. Missing either one is a direct path to claim denial.
Sacrocolpopexy is covered for vaginal apical prolapse repair. This is one of the better-established procedures in this policy, and Aetna's coverage language is relatively straightforward here.
Tension-free vaginal tape (TVT) surgery is covered when pelvic organ prolapse is complicated by stress urinary incontinence. The complication must be documented — stress urinary incontinence can't be implied from the prolapse diagnosis alone.
Whether prior authorization applies to any of these in your market depends on the specific Aetna plan. The CPB 0858 policy document doesn't mandate prior auth universally, but many Aetna commercial plans require it for surgical procedures. Confirm prior authorization requirements with the specific plan before scheduling.
Aetna Organ Prolapse Exclusions and Non-Covered Indications 2026
This is where the January 5, 2026 effective date hits hardest. Eleven procedures are now explicitly labeled experimental, investigational, or unproven. The policy language is clear: "the effectiveness of these approaches has not been established."
Biodegradable cog threads for pelvic organ prolapse are out. This is a newer technique that has attracted clinical interest, but Aetna is not following that interest with reimbursement. Any claim using this approach will be denied.
Biologic grafts — including the Coloplast Axis Dermis Biological graft — are excluded for vaginal apical prolapse repair. This is a meaningful distinction from synthetic mesh, which has its own covered pathway under sacrocolpopexy. Don't assume biologic materials get the same treatment as synthetic.
Genetic testing for pelvic organ prolapse is explicitly non-covered. The entire molecular pathology CPT range from 81400 through 81474 is tied to this exclusion. If your urogynecology practice has started offering genetic counseling alongside prolapse workups, this should go through your compliance officer before you bill Aetna for it.
Laser therapy (CPT 0552T) is excluded. This is consistent with Aetna's posture on laser therapy for other pelvic floor conditions — they've been skeptical of it across multiple CPBs for years.
Pectopexy is excluded. This laparoscopic fixation technique has been gaining traction in Europe, but Aetna doesn't consider it proven.
Transcutaneous electrical nerve stimulation (TENS) for prolapse is excluded. Note this is specifically for prolapse treatment — Aetna's related policy CPB 0223 addresses pessary for pelvic organ prolapse.
Trans-vaginal absorbable meshes or biological grafts for vaginal prolapse are excluded. This follows the FDA's positioning on transvaginal mesh and reflects ongoing safety and efficacy concerns.
vNOTES presacral-uterosacral hysteropexy and vaginal NOTES uterosacral ligament suspension are both excluded. These are minimally invasive approaches that have generated research interest, but Aetna isn't covering either.
Vaginal tactile imaging (CPT 0487T) for diagnosis and evaluation of vaginal and pelvic floor conditions is excluded. This one is worth flagging specifically — some practices bill 0487T as a diagnostic tool without realizing it falls outside this coverage policy.
The real issue here is that several of these exclusions involve procedures that are actively marketed to patients and practiced in academic centers. The gap between clinical adoption and payer coverage is wide on this policy. Your billing team needs to flag these before the patient ever gets to the OR.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Dynamic MRI for complex organ prolapse | Covered | — | Must supplement physical exam, not replace it |
| Laparoscopic suture rectopexy for rectal prolapse | Covered | — | Laparoscopic approach is the only approach explicitly listed as medically necessary; document in operative note |
| LeFort colpocleisis for severe utero-vaginal prolapse | Covered | — | Patient must be elderly or chronically ill AND no longer desire coital function; both criteria must be documented |
| Sacrocolpopexy for vaginal apical prolapse repair | Covered | — | Well-established coverage; verify prior auth per plan |
| TVT surgery for prolapse with stress urinary incontinence | Covered | — | SUI must be independently documented |
| Biodegradable cog threads | Experimental | — | Not covered; claim denial expected |
| Biologic graft (e.g., Coloplast Axis Dermis) for vaginal apical prolapse | Experimental | +57267, 57285 | Distinct from covered synthetic mesh pathway |
| Combined laparoscopic-vaginal lateral suspension | Experimental | — | Not covered |
| Genetic testing for pelvic organ prolapse | Experimental | 81400–81474 | Entire molecular pathology range is excluded for this indication |
| Laser therapy for pelvic organ prolapse | Experimental | 0552T | Consistent with Aetna's broader laser therapy posture |
| Pectopexy | Experimental | — | Not covered despite growing clinical use |
| TENS for pelvic organ prolapse | Experimental | — | CPB 0223 addresses pessary for pelvic organ prolapse separately |
| Trans-vaginal absorbable meshes or biological grafts | Experimental | +57267, 57284, 57285 | Follows FDA safety posture on transvaginal mesh |
| vNOTES presacral-uterosacral hysteropexy | Experimental | — | Not covered |
| Vaginal NOTES uterosacral ligament suspension | Experimental | — | Not covered |
| Vaginal tactile imaging (diagnosis/evaluation) | Experimental | 0487T | Excluded even as a diagnostic tool |
Aetna Organ Prolapse Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Audit your charge capture for CPT 0487T now. This code for vaginal tactile imaging is explicitly excluded under CPB 0858 effective January 5, 2026. If your practice has been billing it for prolapse diagnosis under Aetna, pull your last 90 days of claims and assess your exposure. |
| 2 | Flag the molecular pathology range 81400–81474 in your Aetna claim edits. Genetic testing for pelvic organ prolapse is non-covered. If your system doesn't already block or flag these codes against an organ prolapse primary diagnosis for Aetna payers, build that rule today. |
| 3 | Update documentation templates for LeFort colpocleisis billing. The medical necessity criteria require explicit documentation of patient age or chronic illness AND the absence of desire for coital function. Both must appear in the clinical note. A claim without both will be denied. Work with your clinical team to add these fields to the surgical pre-authorization and operative note templates before the January 5, 2026 effective date. |
| 4 | Verify prior authorization requirements plan by plan before scheduling prolapse surgery. CPB 0858 itself doesn't list a universal prior auth requirement, but individual Aetna commercial plans often do for surgical procedures. Call the plan or check your provider portal for each patient before the procedure is scheduled. A missing prior auth is a preventable write-off. |
| 5 | Separate biologic graft billing from synthetic mesh billing in your charge capture. Biologic grafts — including the Coloplast Axis Dermis product — are excluded. Synthetic mesh procedures under sacrocolpopexy remain covered. If your coders use +57267 for mesh insertion without distinguishing graft type in the documentation, you have a claim denial risk. Add a documentation prompt to your operative note template specifying synthetic vs. biologic material. |
| 6 | Review trans-vaginal mesh and graft claims under codes 57284 and 57285. These paravaginal repair codes appear in the experimental grouping for trans-vaginal absorbable meshes and biological grafts. If your billing team is attaching these codes to a transvaginal approach with mesh or biologic material, expect denials. Verify the approach and material type before billing. |
| 7 | Talk to your compliance officer if you perform any of the 11 excluded procedures. If your practice uses pectopexy, vNOTES techniques, biodegradable cog threads, or laser therapy for prolapse and you're billing Aetna, you need a compliance review before the January 5, 2026 effective date. These aren't gray areas — Aetna has named them explicitly. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Organ Prolapse Under CPB 0858
Not Covered / Experimental CPT Codes
These codes are tied to procedures Aetna classifies as experimental, investigational, or unproven under CPB 0858. Billing these codes against a pelvic organ prolapse diagnosis for Aetna will result in denial.
| Code | Type | Description | Linked Exclusion |
|---|---|---|---|
| 0487T | CPT | Biomechanical mapping, transvaginal, with report | Vaginal tactile imaging |
| 0552T | CPT | Low-level laser therapy, dynamic photonic and dynamic thermokinetic energies | Laser therapy for POP |
| +57267 | CPT | Insertion of mesh or other prosthesis for repair of pelvic floor defect, each site | Biodegradable cog threads; transvaginal mesh/biologic graft |
| 57284 | CPT | Paravaginal defect repair; open abdominal approach | Transvaginal absorbable meshes or biological grafts |
| 57285 | CPT | Paravaginal defect repair; vaginal approach (with biologic graft) | Transvaginal absorbable meshes or biological grafts |
| 81400 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81401 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81402 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81403 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81404 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81405 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81406 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81407 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81408 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81409 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81410 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81411 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81412 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81413 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81414 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81415 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81416 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81417 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81418 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81419 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81420 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81421 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81422 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81423 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81424 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81425 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81426 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81427 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81428 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81429 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81430 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81431 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81432 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81433 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81434 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81435 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81436 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81437 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81438 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81439 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81440 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81441 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81442 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81443 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81444 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81445 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81446 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81447 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81448 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81449 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81450 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81451 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81452 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81453 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81454 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81455 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81456 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81457 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81458 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81459 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81460 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81461 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81462 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81463 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81464 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81465 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81466 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81467 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81468 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81469 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81470 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81471 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81472 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81473 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
| 81474 | CPT | Tier 2 Molecular Pathology Procedures | Genetic testing for POP |
Note: The policy data references 10 additional CPT codes and 9 HCPCS codes not fully enumerated in the source data. Review the full CPB 0858 policy document at Aetna's clinical policy bulletin library for the complete code list.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.